ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $18,554,000 | -19.4% | 107,808 | -41.2% | 0.07% | -15.9% |
| Q2 2021 | $23,012,000 | +13.3% | 183,374 | +22.5% | 0.08% | -2.4% |
| Q1 2021 | $20,306,000 | -18.6% | 149,740 | -23.2% | 0.08% | -27.0% |
| Q4 2020 | $24,935,000 | +94.9% | 194,897 | +71.4% | 0.12% | +57.5% |
| Q3 2020 | $12,794,000 | +70.5% | 113,692 | +44.4% | 0.07% | +43.1% |
| Q2 2020 | $7,503,000 | +353.6% | 78,756 | +327.9% | 0.05% | +264.3% |
| Q1 2020 | $1,654,000 | +48.2% | 18,404 | -12.6% | 0.01% | +75.0% |
| Q4 2019 | $1,116,000 | – | 21,058 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |